Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Nordic Capital acquires SaaS fintech Zafin
Nordic Capital is to acquire a majority stake in Zafin, a provider of SaaS core modernisation and transformation solutions for financial institutions around the world. The firm’s founders and management are reinvesting in the company as part of the deal. Zafin’s core...
Värde commits $1.3bn in asset-based private credit deals in 2023
Värde Partners, a global alternative investment firm specialising in credit and credit-related strategies, committed $1.3bn across its asset-based lending and diversified private credit platform during 2023. The investments facilitated approximately $9bn of commercial...
Blue Owl leads $2bn RLDatix private credit loan
Healthcare software specialist RLDatix is to refinance its existing debt facilities with a new $2bn-plus private credit loan led by Blue Owl Capital, with Ares Management and Golub Capital also significant participants in the deal, according to a report by Bloomberg....